Back to search

Article

IRSN-23 Gene Diagnosis Predicts Response to Neoadjuvant Chemotherapy and Refines Breast Cancer Subtype Classification (Prospective Analyses)

2024-08-15

Abstract excerpt

<title>Abstract</title> <p>Introduction: This study evaluates the reproducibility of the IRSN-23 model, which classifies patients into highly chemotherapy-sensitive (Gp-R) or less-sensitive (Gp-NR) groups based on immune-related gene expression using DNA microarray analysis, and its impact on breast cancer subtype classification. <h4>Methods:</h4> Tumor tissues from 146 breast cancer patients receiving preoperati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dbca613d-a87a-560c-ae39-3707f5ed3a3a
DOI
10.21203/rs.3.rs-4860616/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
IRSN-23 Gene Diagnosis Predicts Response to Neoadjuvant Chemotherapy and Refines Breast Cancer Subtype Classification (Prospective Analyses)DOI 10.21203/rs.3.rs-4860616/v1
Combination of Immune-Related Network and Subtype-Specific Analysis Define a Three- Gene Panel for Predicting Prognosis of Triple-Negative Breast CancerSemantic proximity
TP53 signature score predicts prognosis and immune response in triple-negative breast cancerSemantic proximity
A novel twelve-gene signature to evaluate neoadjuvant chemotherapy response and predict prognosis in breast cancerSemantic proximity
Construction and validation of a gene expression classifier to predict immunotherapy response in primary triple-negative breast cancerSemantic proximity
The Early-Stage Triple-Negative Breast Cancer Landscape Derives a Novel Prognostic Signature and Therapeutic TargetSemantic proximity
Combination of Immune-Related Network and Molecular Typing Analysis Defines a Three-Gene Signature for Predicting Prognosis of Triple-Negative Breast CancerSemantic proximity
Genomic Characteristics of Triple-Negative Breast Cancer Nominate Molecular Subtypes That Predict Chemotherapy ResponseSemantic proximity
Novel biomarkers and prediction model for the pathological complete response to neoadjuvant treatment of triple-negative breast cancerSemantic proximity
Predictive Value of Immune Genomic Signatures from Breast Cancer Cohorts Containing Data for Both Response to Neoadjuvant Chemotherapy and Prognosis after SurgerySemantic proximity
Integrated genomic profiling identifies predictive biomarkers for neoadjuvant therapy response in Chinese breast cancer patients.Semantic proximity
Immune Effective Score As A Predictor Of Response To Neoadjuvant Trastuzumab Therapy And A Prognostic Indicator For HER2-positive Breast CancerSemantic proximity
A novel gene signature to predict response to neoadjuvant chemotherapy and endocrine treatment in estrogen receptor-positive breast cancer patientsSemantic proximity
Select a neighboring publication to make it the new centre.